1788
M.A. Tarselli et al. / Tetrahedron 65 (2009) 1785–1789
4. Conclusion
60.9, 56.3, 56.1, 25.7, 22.6, 17.7. HRMS (ESIþ): expected 289.1416,
observed 289.1422 (MþNaþ).
A method for the addition of methoxybenzenes to allenes by
phosphite-gold(I) catalysts was reported. The reactions were stable
to air and trace moisture, and were conducted on the benchtop in
air. Electron-rich methoxybenzenes and unhindered mono-
substituted allenes were found to be the best participants in these
reactions.
5.6. 2-Methyl-4-(1,2,3-trimethoxyphenyl)-but-2-ene (9)
Clear oil. 1H NMR (400 MHz):
d 6.80 (d, 1H), 6.59 (d, 1H), 5.24 (t,
1H), 3.88 (s, 3H), 3.86 (s, 3H), 3.82 (s, 3H), 3.25 (d, 2H), 1.72 (s, 6H).
13C NMR (100 MHz): 152.0, 151.8, 142.5, 131.9, 127.9, 123.5, 123.3,
107.5, 60.7, 56.0, 28.2, 25.7, 17.1.
5. Experimental section
5.1. General
5.7. 2-Methyl-4-(5-methyl-1,2,3-trimethoxyphenyl)-but-2-
ene (11)
All gold precatalysts were synthesized according to the pub-
lished methods.4,13,14 Silver bistriflimide (AgNTf2) was formed
according to the procedure of Gagosz.19 All other silver salts were
purchased from Strem Chemicals and stored in a nitrogen-atmo-
sphere glovebox, then transferred to an oven-dried vial stored in
a desiccator when used. All solvents were purified by alumina-
packed columns under Ar or distillation from Na0 or CaH2. Arenes
were purchased from Aldrich and used as received. Dimethylallene
and ethyl-2,3-butadienoate were purchased from Aldrich; alle-
nylmalonate was synthesized according to the literature
procedure.20
1H NMR (400 MHz): 1.66 (s, 3H), 1.75 (s, 3H), 2.22 (s, 3H), 3.26
(d, 2H), 3.79–3.83 (m, 9H), 5.02 (t, 1H), 6.48 (s, 1H). 13C NMR
(100 MHz): 151.8, 151.1, 140.5, 131.8, 131.0, 126.3, 123.2, 109.6, 60.9,
60.8, 55.9, 25.6, 19.6, 17.8.
5.8. Dimethyl-2-(E-4-(1,3,5-trimethoxyphenyl)-but-2-
enyl)malonate (13)
Clear oil. 1H NMR (300 MHz):
d 6.09 (s, 2H), 5.58 (dt, 1H,
J¼15.3 Hz), 5.29 (dt, 1H, J¼15.0 Hz), 3.78 (s, 3H), 3.75 (s, 6H), 3.65
(s, 6H), 3.35 (t, 1H, J¼7.5 Hz), 3.20 (d, 2H, J¼6 Hz), 2.51 (t, 2H,
J¼14.7 Hz). 13C NMR (100 MHz): 169.4, 159.5, 158.7, 132.3, 124.5,
109.4, 90.8, 55.7, 55.3, 52.2, 52.1, 31.9, 25.6. HRMS (ESIþ): expected
375.1482, observed 375.1482 (MþNaþ).
5.2. General procedure for intermolecular hydroarylation
To a 5-mL vial charged with a stirbar were added (4-ClPhO)3
-
PAuCl (9.6 mg, 15
mmol) and AgBF4 (3.0 mg, 15 mmol), and
5.9. Dimethyl-2-(E-4-(1,3-dimethoxyphenyl)-but-2-enyl)-
malonate (14a) and dimethyl-2-(E-4-(2,5-dimethoxyphenyl)-
but-2-enyl)malonate (14b)
dichloromethane (1.0 mL) by syringe, resulting in a light gray
suspension. After stirring for 2 min, 1,3,5-trimethoxybenzene
(100 mg, 0.6 mmol) was added, resulting in a color change to
light orange. After stirring for additional 2 min, dimethylallene
(20.0 mg, 0.3 mmol) was added dropwise by microsyringe. Stir-
ring was continued until GC/TLC (product Rf 0.5 in 1:7 ethyl acetate/
hexanes) analysis indicated complete consumption of the allene.
The reaction mixture was concentrated, loaded directly onto a silica
flash column, and eluted with 1:10 to 1:8 ethyl acetate/hexanes to
6:1 mixture, inseparable by column chromatography. Compound
14a. 1H NMR (300 MHz):
d 2.57 (t, 2H), 3.19 (d, 2H), 3.40 (t, 1H),
3.67 (s, 6H), 3.76 (s, 6H), 5.40 (dt, 1H, J¼15.2 Hz), 5.63 (dt, 1H,
J¼15.2 Hz), 6.38 (m, 2H), 6.94 (d, 1H). 13C NMR (100 MHz) (mix-
ture): 169.4, 160.9, 159.4, 158.1, 132.4, 129.9, 129.8, 125.9, 124.9,
121.3,106.2,104.0,102.9,100.5, 98.5, 55.7, 55.3, 55.3, 55.2, 52.2, 51.9,
32.2, 31.9, 15.2. HRMS (ESI): expected 345.1314, observed 345.1329
(MþNaþ).
yield 3 (67% yield) as a clear oil. 1H NMR (300 MHz):
d 6.13 (s, 2H),
5.16 (t, 1H), 3.79 (s, 9H), 3.26 (d, 2H), 1.75 (s, 3H), 1.65 (s, 3H). 13C
NMR (100 MHz): 159.9, 158.7, 130.6, 123.5, 111.0, 90.9, 55.7, 55.3,
25.8, 21.8, 17.6.
5.10. Ethyl-E-4-(1,3,5-trimethoxyphenyl)-but-2-enoate (16)
5.3. Tri(4-chlorophenyl)phosphite gold(I) chloride
Clear oil. 1H NMR (300 MHz):
d
7.01 (dt, 1H, J1¼15.6 Hz,
White crystalline solid. 1H NMR (CDCl3, 300 MHz):
d 7.37 (d, 2H,
J2¼6 Hz), 6.10 (s, 2H), 5.66 (dt,1H, J¼15.3 Hz), 4.11 (m, 2H), 3.79 (s,
3H), 3.76 (s, 6H), 3.42 (dd, 2H), 1.23 (t, 3H). 13C NMR (100 MHz):
167.2, 160.1, 158.8, 148.1, 129.3, 120.6, 116.7, 106.6, 104.2, 90.6, 59.9,
55.3, 25.5, 14.3. HRMS (ESIþ): expected 281.1389, observed
281.1387 (MþHþ).
J¼9 Hz), 7.12 (dd, 2H, J1¼9 Hz, J2¼1.8 Hz). 13C NMR (100 MHz):
d
147.6, 132.5, 130.6, 122.3 (d). 31P (121 MHz):
d 112.0.
5.4. 2-Methyl-4-(2,4-dimethoxyphenyl)-but-2-ene (5a) and 2-
methyl-4-(2,6-dimethoxyphenyl)-but-2-ene (5b)
5.11. 1-(1,3,5-Trimethoxyphenyl)-2E-triskadecene (18)
6:1 Mixture, inseparable by column chromatography. Compound
5a. 1H NMR (400 MHz): 1.68 (s, 3H), 1.71 (s, 3H), 3.22 (d, 2H), 3.77
(s, 3H), 3.79 (s, 3H), 5.26 (t,1H), 6.42 (m, 2H), 7.01 (d,1H). Compound
5b. 1H NMR (400 MHz): 1.65 (s, 3H), 1.74 (s, 3H), 3.32 (d, 2H), 3.79
(s, 3H), 3.80 (s, 3H), 5.19 (t, 1H), 6.53 (d, 2H), 7.09 (t, 1H). 13C NMR
(100 MHz) (mixture): 159.1, 158.1, 129.4, 123.3, 123.0, 122.6, 103.9,
98.6, 55.8, 55.3, 27.8, 25.8, 17.7.
Clear oil. 1H NMR (400 MHz):
d 0.85 (t, 4H), 1.22 (m, 22H), 1.90
(m, 2H), 3.22 (d, 2H), 3.79 (m, 12H), 5.40 (m, 2H), 6.12 (s, 2H). 13C
NMR (100 MHz): 159.3, 158.8, 130.0, 128.3, 90.9, 55.8, 55.3, 32.5,
31.9, 29.6, 29.5, 29.3, 29.2, 25.7, 22.7, 14.1. HRMS (ESIþ): expected
371.2562, observed 371.2583 (MþNaþ).
Acknowledgements
5.5. 2-Methyl-4-(1,2,3,5-tetramethoxyphenyl)-but-2-ene (7)
The authors gratefully acknowledge the National Institutes of
Health Institute of General Medicine (GM-60578) for support
of this research. We also thank John Gipson for the preparation of
phenylallene and benzylallene (Scheme 4).
1H NMR (400 MHz):
d 6.24 (s, 1H), 5.11 (t, 1H), 3.82 (s, 3H), 3.81
(s, 3H), 3.77 (s, 3H), 3.23 (d, 2H), 1.72 (s, 3H), 1.62 (s, 3H). 13C NMR
(100 MHz): 153.6, 152.4, 151.6, 130.7, 123.6, 116.5, 100.0, 93.1, 60.9,